Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Equity (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Equity for 15 consecutive years, with 0.96% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 21.0% to 0.96% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.96%, a 21.0% decrease, with the full-year FY2024 number at 0.66%, down 26.0% from a year prior.
  • Return on Equity was 0.96% for Q3 2025 at Creative Medical Technology Holdings, down from 0.77% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 28.82% in Q3 2021 to a low of 1.0% in Q1 2022.
  • A 5-year average of 1.65% and a median of 0.65% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: surged 2797bps in 2021, then tumbled -2917bps in 2022.
  • Creative Medical Technology Holdings' Return on Equity stood at 3.9% in 2021, then plummeted by -114bps to 0.53% in 2022, then rose by 12bps to 0.47% in 2023, then plummeted by -81bps to 0.85% in 2024, then fell by -13bps to 0.96% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Return on Equity are 0.96% (Q3 2025), 0.77% (Q2 2025), and 0.85% (Q1 2025).